Cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies.
View all
Pulse Biosciences
Post IPO Equity • Hayward, United States
Bolt Biotherapeutics
Post IPO Equity • Redwood City, United States
Translate Bio
Post IPO Equity • Lexington, United States
Sorrento Therapeutics
Post IPO Equity • San Diego, United States
Quince Therapeutics
Post IPO Equity • South San Francisco, United States
Cara Therapeutics
Post IPO Equity • Stamford, United States
Kymera Therapeutics
Post IPO Equity • Watertown, United States
Celldex Therapeutics
Post IPO Equity • Hampton, United States
Kura Oncology
Post IPO Equity • San Diego, United States
Karuna Therapeutics
Post IPO Equity • Boston, United States
OncoSec
Post IPO Equity • San Diego, United States
Otonomy
Post IPO Equity • San Diego, United States